Ftse Mib
34.374,77
0,55%
DAX
20.024,66
0,58%
S&P 500
5.868,55
-0,22%
NASDAQ
19.280,79
-0,16%
Bitcoin
96.817,40
-0,08%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ First Wave BioPharma Inc (FWBI) First Wave BioPharma Inc (FWBI) Notizie

First Wave BioPharma Inc

FWBI
2,96
0,00 (0,00%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/9/202423:10EDGAR2Form 8-K - Current report
10/9/202413:00EDGAR2Form 8-K - Current report
03/9/202422:05EDGAR2Form 8-K - Current report
29/8/202422:05EDGAR2Form 8-K - Current report
23/8/202423:00EDGAR2Form 8-K - Current report
22/8/202423:28EDGAR2Form 8-K - Current report
15/8/202414:05EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
15/8/202414:00EDGAR2Form 8-K - Current report
15/8/202403:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/8/202423:20EDGAR2Form 8-K - Current report
31/7/202416:54EDGAR2Form 8-K - Current report
26/7/202422:16EDGAR2Form S-3 - Registration statement under Securities Act of..
23/7/202422:05EDGAR2Form 8-K - Current report
11/7/202414:00EDGAR2Form 8-K - Current report
03/7/202420:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/6/202414:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/6/202422:30EDGAR2Form 8-K - Current report
17/6/202423:23EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
14/6/202423:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/6/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
05/6/202423:15EDGAR2Form 8-K - Current report
31/5/202423:25EDGAR2Form S-3 - Registration statement under Securities Act of..
30/5/202423:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/5/202423:18EDGAR2Form 8-K/A - Current report: [Amend]
16/5/202413:16EDGAR2Form 8-K - Current report
16/5/202413:00GLOBEFirst Wave BioPharma Changes Name to Entero Therapeutics
14/5/202423:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202423:26EDGAR2Form 8-K - Current report
13/5/202422:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/5/202413:55GLOBEFirst Wave BioPharma, Inc. to raise approximately $1.1..
09/5/202413:00GLOBEFirst Wave BioPharma and Celiac Journey to Host Nasdaq Event..
08/5/202423:16EDGAR2Form 8-K/A - Current report: [Amend]
24/4/202413:00GLOBEFirst Wave BioPharma Announces Invited Paper for Special..
17/4/202413:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Present at the..
15/4/202413:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Participate in..
18/3/202412:00GLOBEFirst Wave BioPharma Announces Two Abstracts on Celiac..
14/3/202411:00GLOBEFirst Wave BioPharma Announces Completion of Business..
05/3/202423:26EDGAR2Form 8-K - Current report
05/3/202413:00GLOBEFirst Wave BioPharma to Participate In ‘Fireside Chat’ at..
04/3/202423:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/3/202414:00GLOBEFirst Wave BioPharma, Inc. to Raise Approximately $4.0..
13/2/202413:00GLOBEFirst Wave BioPharma CEO to Present at the BIO CEO &..
23/1/202413:00GLOBEFirst Wave BioPharma to Present at the DealFlow MicroCap..
18/1/202422:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202413:00GLOBEFirst Wave BioPharma CEO to Present at the Sequire Investor..
08/1/202423:14EDGAR2Form S-3 - Registration statement under Securities Act of..
04/1/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202414:22EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 2,96

La tua Cronologia

NASDAQ
FWBI
First Wave BioPharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network